These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8620461)
1. Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings. Dueñas-González A; Abad-Hernández MM; García-Mata J; Paz-Bouza JI; Cruz-Hernández JJ; González-Sarmiento R Cancer Lett; 1996 Mar; 101(2):137-42. PubMed ID: 8620461 [TBL] [Abstract][Full Text] [Related]
2. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493 [TBL] [Abstract][Full Text] [Related]
3. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878 [TBL] [Abstract][Full Text] [Related]
4. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131 [TBL] [Abstract][Full Text] [Related]
5. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Marone M; Scambia G; Ferrandina G; Giannitelli C; Benedetti-Panici P; Iacovella S; Leone A; Mancuso S Br J Cancer; 1996 Oct; 74(7):1063-8. PubMed ID: 8855975 [TBL] [Abstract][Full Text] [Related]
6. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer. Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G Oncology; 1998; 55(4):357-62. PubMed ID: 9663428 [TBL] [Abstract][Full Text] [Related]
7. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma]. Zhou Y; Xu A; Ling X Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166 [TBL] [Abstract][Full Text] [Related]
8. P53 is a regulator of the metastasis suppressor gene Nm23-H1. Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312 [TBL] [Abstract][Full Text] [Related]
9. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters. Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901 [TBL] [Abstract][Full Text] [Related]
11. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. Sawan A; Lascu I; Veron M; Anderson JJ; Wright C; Horne CH; Angus B J Pathol; 1994 Jan; 172(1):27-34. PubMed ID: 7931824 [TBL] [Abstract][Full Text] [Related]
12. [Low expression of nm23-H1 mRNA and its protein in breast cancer]. Guo W; Wang Y; Zhuang X; Bai Y; Zhang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528 [TBL] [Abstract][Full Text] [Related]
13. [Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis]. Zhang S; Ye S; Lin H Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):418-21. PubMed ID: 8697991 [TBL] [Abstract][Full Text] [Related]
14. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas. Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431 [TBL] [Abstract][Full Text] [Related]
15. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival. Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T BMC Cancer; 2001; 1():3. PubMed ID: 11319942 [TBL] [Abstract][Full Text] [Related]
16. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496 [TBL] [Abstract][Full Text] [Related]
17. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979 [TBL] [Abstract][Full Text] [Related]
18. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591 [TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers. Okubo T; Inokuma S; Takeda S; Itoyama S; Kinoshita K; Sugawara I Cell Biophys; 1995 Jun; 26(3):205-13. PubMed ID: 8521452 [TBL] [Abstract][Full Text] [Related]
20. [nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma]. Liang C; Xu G Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):391-3. PubMed ID: 11387948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]